论文部分内容阅读
本品是广州侨光制药厂国内首创独家生产的新一代喹诺酮类广谱抗菌注射液,该注射液是参照德国拜耳药厂产品Ciproxin—200(乳酸环丙沙星注射液)的处方设计、研制。其特点是: 1、抗菌谱广——包括耐青霉素的金黄色葡萄球菌和假单孢菌都有效。比其它氟喹诺诺酮类药物有更广的抗菌谱。为全球医药界评价最高的抗感染药物之一。
This product is a new generation of quinolone broad-spectrum antibacterial injection produced by Guangzhou Qiaoguang Pharmaceutical Factory, the first of its kind in China. The injection is based on the prescription design of Ciproxin-200 (ciprofloxacin lactate lactate injection) . Its features are: 1, broad antibacterial spectrum - including penicillin-resistant Staphylococcus aureus and Pseudomonas are effective. A broader spectrum of antibacterial activity than other fluoroquinolones. One of the highest rated anti-infective drugs in the global pharmaceutical community.